glassware with magnetic stirring under an atmosphere of dry nitrogen. Reaction progress was monitored by analytical thin layer chromatography (TLC) using 250 µm silica gel plates . Visualization was accomplished with UV light and potassium permanganate stain, followed by heating. Proton nuclear magnetic resonance ( 1 H NMR) spectra were recorded on either a Varian-300 instrument (300 MHz), Varian-400 instrument (400 MHz) or a Varian-500 instrument (500 MHz). Chemical shifts of the compounds are reported in ppm relative to tetramethylsilane (TMS) as the internal standard. Data are reported as follows: chemical shift, integration, multiplicity (s=singlet, d=doublet, t=triplet, q=quartet, br=broad, m=multiplet) , and coupling constants (Hz).
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METHODS
Synthesis of DexAM
1.1
Synthesis of hexamethyl-3,3',3'',3''',3'''',3'''''-(2,2',2''-nitrilotris(ethane-2,1-diyl) 
tris(azanetriyl)) hexapropanoate (2)
A solution of tris(aminoethyl)amine (1, 4.3872g, 30 mmol) in methanol (25 mL) was added dropwise to a stirred solution of methyl acrylate (19.37 g, 225 mmol) in methanol (25 mL) for 1 h in an ice-water bath. The resulting solution was stirred for 1 h in an ice-water bath and then allowed to warm to room temperature and stirred for further 48 h. The solvent and excess acrylate were removed under reduced pressure using a rotary evaporator. The residue was purified by column chromatography to afford the product (2) as a colorless oil. Yield: 16.88 g, 85% 1.2 3,3',3'',3''',3'''',3'''''-(2,2',2''-nitrilotris(ethane-2,1-diyl) tris(azanetriyl))hexakis (N-(2-(bis(2-aminoethyl) 
A solution of 2 (2.17 g, 3.3 mmol) in methanol (20 mL) was added dropwise to solution of tris(aminoethyl)amine (1, 5.8 g, 39.6 mol) in methanol (20 mL) and stirred over a period of 1 h in an ice bath. The resulting solution was allowed to warm to room temperature and stirred for 7 days at room temperature at which time no methyl ester was detectable by NMR spectroscopy.
The solvent was removed under reduced pressure using a rotary evaporator and then the excess tris(aminoethyl)amine was removed using an azeotropic mixture of toluene and methanol (90:10 v/v). The remaining toluene was removed by azeotropic distillation using methanol. Finally, the remaining methanol was removed under vacuum. The residue was purified by dialysis and centrifugal filtration to afford the desired product. Finally the product was (5) A solution of ester 4 (3.41g, 1 mmol) in methanol (20 mL) was added dropwise to a stirred solution of tris(aminoethyl)amine (1, 7.02 g, 48 mmol) in methanol (20 mL) over a period of 1 h in an ice bath. The resulting solution was allowed to warm to room temperature and stirred for 7 days at room temperature at which time no methyl ester was detectable by NMR spectroscopy.
Synthesis of the polyamine backbone of DexAM
The solvent was removed under reduced pressure the excess tris(aminoethyl)amine was removed using an azeotropic mixture of toluene:MeOH (90:10 v/v). The product was further purified by washing with anhydrous ether twice, yielding a highly viscous liquid. Finally the product was kept under vacuum to provide the amino-terminated final product (5) 
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Scheme 3. Conjugation of β-CD to the Polyamine Backbone, a) ddH 2 O, RT, 4h / 1 % NaOH, 10 min/NH 4 Cl, b) DMF, 90°C, 48h, c) Amberlite IRA900 (7) β-cyclodextrin (6, 8.75 g, 7.71 mmol) and tosylimidazole (2.22g, 10.0 mmol) was dissolved in 88 ml deionized water. The solution was vigorously stirred for 4 h at room temperature. Aqueous NaOH solution (1% (w/v), 10.0 ml) was gradually added to the solution and stirred for an additional 10 min. The insoluble solid was filtered off and the filtrate was collected. The filtrate was neutralized to pH 7 using NH 4 Cl to induce precipitation. The precipitate was then collected by filtration, washed with cold water (25 ml ⅹ3) and with acetone (25 ml ⅹ4). (dendrimer methylene), 2.51-2.11 (dendrimer methylene).
Synthesis of mono-tosylated cyclodextrin
Procedure for RA inclusion in DexAM
3 molar equivalent of Retinoic acid (RA) was solubilized in 1 molar equivalent of DexAM in distilled water. Briefly, 11.5 mg of RA was added to a solution of 123 mg of DexAM in 3 mL of water, heated and refluxed overnight, and then rapidly cooled to room temperature. The reaction mixture turned to dark brown color after overnight reflux. This solution was filtered and freeze-dried. Thereafter, 200 µL PBS was added to DexAM complex (10 µmol) and allowed to stand at room temperature to dissolve for a few minutes. Finally, the complex was purified through by centrifugal filtration using a 3000 MWCO membrane (Millipore). DexAM-RA solutions of various concentrations were prepared by maintaining the molar ratio between RA and DexAMs.
Measuring RA Encapsulation Efficiency
A suspension of DexAM (40 mg) and varying mole equivalents of RA was refluxed in distilled water. After cooling to room temperature, the reaction mixture is diluted with excess water and extracted with dichloromethane to isolate free RA. The organic phase was washed with brine, dried over sodium sulfate and concentrated in vacuo. The amount of RA was measured using UV-visible spectroscopy and each reaction was carried out twice. Figure S6 displays the percent RA encapsulation per β-CD on the DexAM versus the mole equivalent of RA. 
Rat Neural Stem Cell (NSC) Culture, Cell Viability Assay & Immunochemistry
NSC Culture and Differentiation
Rat neural stem cell line (Millipore) were purchased and routinely expanded according to the manufacture's protocol. The NSCs were maintained in laminin (Sigma, 20 µg/ml) coated culture dishes precoated with poly-L-lysine (10 µg/ml) in Millitrace media (Millipore) supplemented with the antibiotics, penicillin and streptomycin (Life Technologies), in the presence of basic fibroblast growth factor (bFGF-2, 20 ng/ml, Millipore). All of the cells were maintained at 37°C in a humidified atmosphere of 5% CO 2 . For consistency, the experiments were carried out on cells between passages 2 and 5. Neural differentiation was initiated by changing the medium to basal medium (without bFGF-2). The cells were allowed to differentiate for 6 days with the basal medium in each being exchanged every other day.
Cell Viability Assay
The percentage of viable cells was determined by MTS assay following standard protocols described by the manufacturer. All experiments were conducted in triplicate and averaged. The quantification of cytotoxicity was done using MTS assay after incubating cells in the presence of the DexAM-siRNA complexes.
Immunocytochemistry
To investigate the extent of neuronal differentiation, at Day 6, the basal medium was removed and the cells fixed for 15 minutes in Formalin solution (Sigma) followed by two PBS washes.
Cells were permeabilized with 0.1% Triton X-100 in PBS for 10 minutes and non-specific binding was blocked with 5% normal goat serum (NGS, Life Technologies) in PBS for 1 hour at room temperature. To study the extent of neuronal differentiation the primary mouse antibody against TuJ1 (1:500, Covance) and primary rabbit antibody against MAP2 (1:100, Cell Signaling) was used and for glial differentiation the primary rabbit antibody against GFAP (1:300, Dako) was used. The fixed samples were incubated overnight at 4°C in solutions of primary antibodies in PBS containing 10% NGS. After washing three times with PBS, the samples were 
